Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Sep;13(3):138-44.
doi: 10.4103/0972-124X.60226.

Biograft-HT as a bone graft material in the treatment of periodontal vertical defects and its clinical and radiological evaluation: Clinical study

Affiliations

Biograft-HT as a bone graft material in the treatment of periodontal vertical defects and its clinical and radiological evaluation: Clinical study

K T Chandrashekar et al. J Indian Soc Periodontol. 2009 Sep.

Abstract

Aim: To determine the efficacy of Biograft-HT((R)) as a bone graft material in the treatment of vertical defects in generalized chronic periodontitis patients and their clinical and radiological evaluation.

Patients and methods: Twenty patients diagnosed with generalized chronic periodontitis having two or more vertical defects were selected for this study. Clinical parameters like plaque index, gingival index, probing pocket depth and clinical attachment levels were recorded at different points of time over six months. Radiographic evaluation included the depth of the bone defect and the percentage of bone defect fill and was carried out for both the groups at baseline, three months and six months. After recording clinical parameters and administering phase-1 therapy, the sites were randomly treated either with Biograft- HT((R)) or open flap debridement only.

Results: At the end of six months there was a significant reduction in the plaque and gingival scores in both test and control groups. There was 64% decrease in probing pocket depth for the test site as compared to 54.52% decrease seen for the control group. Similarly there was an 84.82% gain in clinical attachment level from the baseline to six months post operatively for the experimental group in comparison to 68.83% gain for the control group. Furthermore, 43.57% bone fill was observed for the experimental site whereas only 17.98% of bone fill was evident in the control site.

Conclusion: Biograft -HT improves healing outcomes, leads to a reduction of probing depth, a resolution of osseous defects and a gain in clinical attachment, compared with open flap debridement by itself.

Keywords: Beta-triclacium phosphate; hydroxyapatite; vertical defects.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None declared.

Figures

Figure 1a
Figure 1a
X-ray of control site at baseline
Figure 1b
Figure 1b
X-ray of control site after six months
Figure 2a
Figure 2a
X-ray of experimental site at baseline
Figure 2b
Figure 2b
X-ray of experimental site after six months
Figure 3a
Figure 3a
Experimental site showing vertical defect
Figure 3b
Figure 3b
Experimental site with bone graft filled
Figure 3c
Figure 3c
Experimental site after suturing
Figure 4a
Figure 4a
Control site showing defect after debridement
Figure 4b
Figure 4b
Control site after suturing
Graph 1
Graph 1
Comparing pocket depth score between experimental and control site mean clinical
Graph 2
Graph 2
Mean clinical attachment lever score between experimental and control site
Graph 3
Graph 3
Comparing clinical attachment gain score between experimental and control site
Graph 4
Graph 4
Comparing bone defect depth score between experimental and control site
Graph 5
Graph 5
Comparing bone defect percentage fill between experimental and control site

Similar articles

Cited by

References

    1. Carranaza FA, Newman MG. Reconstructive osseous surgery. 8th ed. Philadelphia, USA: WB Saunders Company; 1999. Clinical Periodontology; pp. 622–39.
    1. Reynolds MA, Aichelmann-Reidy ME, Branch Mays GI, Gunsolley JC. The efficacy of bone replacement grafts in the treatment of periodontal osseous defects. Ann Periodontol. 2003;8:227–65. - PubMed
    1. Nasr HF, Aichelmann Reidy, Yukna RA. Bone and bone substitutes. Periodontology 2000. 1999;19:74–86. - PubMed
    1. Stahl SS, Froum S. Human intrabony lesion responses to debridement, porous hydroxyapatite implants and teflon barrier membranes. J Clin Periodontol. 1991;18:605–10. - PubMed
    1. Kohad RM, Shetty S, Yeltiwar RK, Vaidya SN. A new synthetic hydroxyapatite – the right answer to bone regeneration. J Ind Soc Periodontol. 2001;4:6–11.